India will be getting vaccines from five additional manufacturers by the end of the 3rd quarter of this year
Bengaluru: While India battles second wave of coronavirus, there is some good news.
India will be getting vaccines from five additional manufacturers, reports ANI. This is expected in the 3rd quarter of this year.
Quoting a source, the agency added, "India currently has 2 Covid-19 vaccines being manufactured locally: Covishield and Covaxin, and we can expect five more vaccines by Q3 2021. These vaccines are Sputnik V vaccine (in collaboration with Dr. Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine. Safety and efficacy are the Union government's primary concerns while granting emergency use authorisation (EUA) to any Covid-19 vaccine in the country".
On the issue of their availability, the source said, "Sputnik is expected to be available latest by June, if all goes well Johnson and Johnson ( Bio E) will be available by August, Cadilla Zydus will also be available by August, Novavex (Serum) by September and Nasal Vaccine (Bharat) by October".
Currently, the government is working meticulously to ensure that there is no laxity in vaccine distribution.
"The Government of India is determined to ensure India remains the pharmacy of the world and Indians have equitable access to the highest quality vaccines in the world. We encourage all Covid-19 vaccine manufacturers to come to India, as the Central Government is ready to provide manufacturing assistance, financial support, and partnership in running and designing clinical trials," the source was quoted additionally.
Read Exclusive COVID-19 Coronavirus News updates, at MyNation.